Plasma biochemical parameters as surrogate prognostic markers in HIV-1 infected patients

Research Journal of Medical Sciences

Volumn 2, Issue 4, 2008, Pages 163-165

  Ajose, O A ^a   Banjoko, S O ^a   Olasode, O A ^a   Oyegunle, V A ^b   Fakunle, J B ^a  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^b OLABISI ONABANJO UNIVERSITY   (Nigeria)

Author keywords

HIV 1; Infected patients; Markers; Prognosis; Surrogate marker

Indexed keywords

ALBUMIN; BICARBONATE; CREATININE; GLOBULIN; POTASSIUM ION; SODIUM ION; UREA;

ALBUMIN BLOOD LEVEL; ANALYZER; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD ANALYSIS; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CHEMICAL PARAMETERS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEVICE; DISEASE MARKER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORBIDITY; MORTALITY; PROGNOSIS; PROTEIN BLOOD LEVEL; SECONDARY INFECTION; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; UREA BLOOD LEVEL;

EID: 77953441439     PISSN: 18159346     EISSN: 19936095     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Beddel, R., K.V. Health, R.S. Hogg, B. Wood, N. Press, B.O. Yip, M.V. Shaighnessy and J.S. Montainer, 2003. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV infected individuals in resource limited settings. Anti. Vir. Ther., 8 (5): 379-384.
2. Elena, C., G. Luisa, T. Pier-Angelo, G. Clara and Z.M. Mauri, 2005. Non expensive low complexity surrogate markel of IgA as marker of immunological and virological failure, Clin. Exp. Immunol., 140: 320.
3. Feldman, J.G,, 2003. Serum albumin is a powerful prediction of survival among HIV-1 infected women. J. Acq. Imm. Deficiency Syndrome, 33 (1): 66-73.
4. Junko, T., A. Ishizaki, H. Gatanaga, Y. Kikuchi, S. Kunwa, M. Hirore and S. Oka et al., 2003. Dilated Cardiomyopathy in an adult Human Immunodeficiency Virus, type 1 Positive patients treated with a Zidovudine containing antiretroviral regimen. Clin. Infec. Dis., 37: e107-e111.
5. Lozano, F., J. Gomez-mateos, J.A. Irles, B. Melendez and E. Martin, 1999. Fulminant Septic shock in AIDS patients caused by disseminated cryptococcosis. Eur. J. Clin. Micro. Infec. Dis., 182: 151-152.
6. Martinez, E. and J.M. Gatell, 1999. Metabolic abnormalities and body fat redistribution in HIV-1 infected patients, lipodystrophy syndrome. Curr. Opinium Infect. Dis., 12 (1): 13-20.
7. Mofenson, L.M., D.R. Harris, J. Mioye and J. Bethel, 2003. Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1 infected children in poor resource settings. Lancet 362 (9396): 1625-1627.
8. Nikolaos, V., N. Kosmas, A. Kontos, C. Eflychiadus, E. Agapitos and T. Kordossis, 2003. Fatal Nucleoside associated lactic acidosis in an Obese woman with Human Immunodeficiency Virus type I infection on a low calorie diet. Scand. J. Infect. Dis., 35 (4): 291-293.
9. Oguntibeju, O. and O. Banjoko, 2003. A study on the Activities of Liver Enzymes in HIV/AIDS patients. J. Med. Sci., 3 (1): 106-109.
10. Olawunnmi, H.O. and P.O. Olatunji, 2006. The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patient. HIV Med, 7: 351.
11. Rubio, C.M., A. Nogues Biau, M. Falguera Sacrest, I. Paig Ganau, N. Lceha and C. Rubio Rivas, 2000. The prognostic markers of survival and progression on HIV-1 infection. A study of CD4 lymphocytes antigen P24 and Viral load during 3 years in a Cohort of 251 patients. An. Med. Int, 17 (10): 533-537.
12. Scot, M.H., 2005. Management of newly diagnosed HIV infection. NEJM., 353 (16): 1202-1210.